With an income increase of 526.56% in the fourth quarter 2021, year on year to cumulative value of $85 million, and with 120 employees, Biodelivery Sciences International Inc 's income per employee grew on trailing twelve month basis to $ 707,167, this marks a new company high for all of 120 employees.
The Healthcare sector has seen employees of 26 other companies achieving higher income per employee. While Biodelivery Sciences International Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 262.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BDSI Net Income per Employee	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Net Income Change	526.56 %	-28.92 %	678.03 %	5.46 %	-
Net Income per Employee (TTM) $	707,167	259,725	282,342	216,517	214,258
BDSI's Total Ranking	# 262	# 0	# 0	# 0	# 0
Seq. Net Income Change	858.01 %	-26.42 %	73.08 %	-48.64 %	8.68 %

BDSI Company Profile >> Back to BDSI Efficiency Comparisons >> Compare BDSI Net Income per Employee to its Competitors

BDSI Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 27
Healthcare Sector	# 39
Overall Market	# 262

Net Income per Employee Statistics
High	Average	Low
$ 707,167	$ -173,341	$ -585,885
(Dec 31 2021)		(June 30. 2015)

Companies with similar Income per Employee for 12 month ending Dec 31 2021, within Healthcare Sector	Income per Employee	Income 12 month ending Dec 31 2021	Number of Employees Dec 31 2021
Ligand Pharmaceuticals Incorporated	1,215,702.13	$ 57.138 Million	47
Entrada Therapeutics Inc	1,179,000.00	$ 179.208 Million	152
Xoma Royalty Corporation	1,128,428.57	$ 15.798 Million	14
Omeros Corporation	1,109,914.29	$ 194.235 Million	175
Cue Health Inc	1,080,225.00	$ 86.418 Million	80
Aeon Biopharma inc	1,025,103.88	$ 8.201 Million	8
Prothena Corporation Public Limited Company	999,626.87	$ 66.975 Million	67
Halozyme Therapeutics Inc	952,033.10	$ 402.710 Million	423
Oramed Pharmaceuticals Inc	830,384.62	$ 10.795 Million	13
Maravai Lifesciences Holdings Inc	776,211.49	$ 337.652 Million	435
Illumina Inc	594,531.25	$ 761.000 Million	1,280
Altamira Therapeutics Ltd	583,085.41	$ 18.659 Million	32
Procept Biorobotics Corporation	577,212.84	$ 512.565 Million	888
Bio rad Laboratories Inc	569,919.73	$ 4,245.902 Million	7,450
Semler Scientific inc	555,548.39	$ 17.222 Million	31
Genfit S a	541,943.02	$ 75.330 Million	139
Regeneron Pharmaceuticals Inc	524,029.85	$ 8,075.300 Million	15,410
Exelixis Inc	457,904.97	$ 525.217 Million	1,147
Amgen Inc	453,307.69	$ 5,893.000 Million	13,000
Check Cap Ltd	452,684.21	$ 17.202 Million	38
Horizon Therapeutics Public Limited Company	411,146.92	$ 534.491 Million	1,300
Prestige Consumer Healthcare Inc	397,477.19	$ 226.562 Million	570
Biocept Inc	396,140.67	$ 17.034 Million	43
Fulgent Genetics Inc	376,665.92	$ 506.239 Million	1,344
Gilead Sciences Inc	364,764.71	$ 6,201.000 Million	17,000

Date modified: 2026-09-08T15:10:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.